The company has made considerable investments in research and clinical studies, with the aim of developing a simple and convenient treatment that can be used by patients independently in the comfort of their own homes. The product of this research is the GONDOLA® device. . This device provides AMPS (Automated Mechanical Peripheral Stimulation)treatment, which has been shown to be effective in treating gait disorders and balance impairments.
Our headquarters are located within the Lausanne Biopôle science park, one of the world’s top research hubs for companies specialized in life sciences.
The company continues to conduct clinical studies with internationally renowned neurologists. It has also received substantial support from the American Parkinson Disease Association APDA, and it is in the process of obtaining FDA approval for the GONDOLA® medical device, which is expected in 2020.
GONDOLA® has been a CE-marked device since 2012. In Europe, so far, patients in Switzerland, Italy, France, Germany, England, Spain and Belgium have benefited from the GONDOLA treatment. The company has also received requests from patients outside of Europe who have traveled to Switzerland from across the globe to experience the benefits of AMPS treatment.
Our HQ in Lausanne
o If you arrive on foot or by metro line M2, follow the path marked in red and enter through the main door of the Lysine building, then down to the floor -1
o If you come by car, the entrance to the garage is indicated by the yellow arrow (directions on Google Maps)
Our office in Stabio
o By train: follow the path marked in red and enter through the main gate of the B&C Swiss complex, then the concierge will show you the way
o By car: the entrance is indicated by the yellow arrow (directions on Google Maps), the concierge will show you where to park